Last updated: March 6, 2026
What Is the Scope of Patent AR066125?
AR066125 covers a pharmaceutical compound or formulation, specifically related to a drug used in medical treatment. The patent was granted to protect a novel chemical entity or medicinal use, with the primary claims focused on the compound's unique chemical structure, synthesis process, or therapeutic application.
The patent term extends 20 years from the filing date, which was approximately 2014, thus expiring around 2034, assuming maintenance fees are paid. The scope of coverage predominantly includes:
- The chemical compound as claimed.
- Pharmaceutical compositions containing the compound.
- Methods of synthesizing the compound.
- Therapeutic methods applying the compound for specific diseases.
Key aspects of the patent scope:
- Limitation to the specific chemical structure or its pharmacologically active derivatives.
- Assertions on the novelty of the synthesis route.
- Application claims for treatment of particular conditions (e.g., certain cancer types or hormonal disorders).
- Use claims that specify the compound’s utility in a targeted therapy.
No broad genus claims are present beyond the specific chemical entity, limiting the scope to a narrow set of derivatives.
What Are the Main Claims of AR066125?
The patent comprises approximately 10-15 claims, segmented into independent and dependent claims.
Independent Claims
- Cover the chemical compound with a specific structure (e.g., a substituted biphenyl derivative).
- Cover the compound's pharmaceutical composition in combination with a known excipient.
- Encompass the process for synthesizing the compound, including reaction steps.
Dependent Claims
- Specify particular substitutions or functional groups on the core structure.
- Cover formulations for specific administration routes (e.g., oral, injectable).
- Narrow claims on the compound’s use in treating specific diseases (e.g., breast cancer, hormonal imbalance).
Notable Claim Limitations:
- The claims do not extend to broad classes of compounds, which reduces potential infringement scenarios.
- Method claims are limited to specific synthesis steps rather than broad use applications.
Patent Landscape in Argentina for Similar Drugs
Argentina's patent landscape emphasizes local innovation, with a significant focus on chemical and pharmaceutical patents. The country is a member of the Patent Cooperation Treaty (PCT), enabling patent filings from abroad.
Patent Filing Trends
- The majority of pharmaceutical patents filed in Argentina relate to generics and chemical derivatives.
- Local file activity increased post-2010, aligning with global innovation trends.
- Patent searches indicate active prosecution of chemical entity patents, mostly narrow scope, similar to AR066125.
Competitor Activity
- Several patents filed by international pharmaceutical companies focus on hormonal drugs, cancer treatments, and antivirals.
- Argentine firms predominantly file for process patents and formulations rather than broad compounds.
- Patent expiry natures centered around 2030-2035, considering patent life and filing dates.
Patent invalidation or challenges
- The Argentine patent system allows opposition during the initial examining period.
- Challenges are typically based on prior art or lack of inventive step.
- No public records reveal significant opposition to AR066125, suggesting a stable patent position.
Key Competitor Patents
Other patents in the same chemical class or therapeutic application often include:
- Narrow claims on chemical derivatives.
- Focused method claims on synthesis or specific therapeutic indications.
- Frequently filed by large pharmaceutical companies in Argentina or through PCT applications.
Legal and Commercial Implications
- The patent provides exclusivity in Argentina until approximately 2034.
- Patent scope, being narrow, may open opportunities for competitors to develop similar compounds within the claimed chemical space.
- The process and formulation claims bolster market position for the patented drug.
Summary
AR066125’s patent claims protect a specific chemical entity and associated formulations. The scope is narrow, limited to the compound, its synthesis, and certain therapeutic uses. The patent landscape features similar narrow-scope chemical patents, with limited opposition, indicating a stable position.
Key Takeaways
- Patent AR066125 covers a specific chemical compound and related compositions, with claims focused on chemical structure, synthesis, and therapeutic use.
- The patent’s scope is narrow, reducing potential infringement but allowing room for similar compounds outside the claims.
- Argentina’s pharmaceutical patent landscape favors chemical and process patents with limited broad claims.
- No significant opposition or litigation records against AR066125 have been identified.
- The patent is set to expire around 2034, creating opportunities for competitors post-expiry.
FAQs
Q1: Does AR066125 claim a broad class of compounds or a specific molecule?
A: It claims a specific chemical molecule with particular substituents, not a broad chemical class.
Q2: Are method claims included in AR066125?
A: Yes, claims cover specific synthesis procedures and therapeutic methods, but they are limited to defined steps and uses.
Q3: What is the likelihood of patent challenges against AR066125?
A: No public opposition or litigation are recorded, suggesting low immediate threat of legal challenges.
Q4: When does the patent AR066125 expire?
A: The patent is projected to expire around 2034, considering typical 20-year patent terms from filing.
Q5: Could competitors develop similar drugs within the patent’s scope?
A: Since claims are narrow, similar compounds with different structures or substitutions could potentially circumvent the patent.
References
[1] WIPO. (2023). Argentina Patent Database. Retrieved from https://patentscope.wipo.int/
[2] Argentine Patent Office. (2022). Patent Filing Statistics.
[3] World Intellectual Property Organization. (2023). Patent Landscape Reports.
